Sana Biotechnology, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
SANA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
188 East Blaine Street, Suite 400, Seattle, WA

Insiders trading volume in the past year

Sana Biotechnology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Flagship Ventures Fund V General Partner LLC 10%+ Owner $133M Jun 6, 2023
Flagship Pioneering Inc. 10%+ Owner $117M +$15M +14.7% Feb 12, 2024
Robert Nelsen Director, 10%+ Owner $68.5M +$10M +17.1% Jun 6, 2024
Keith Crandell 10%+ Owner $68.5M +$10M +17.1% Feb 8, 2024
ARCH Venture Fund X, L.P. 10%+ Owner $68.5M +$10M +17.1% Feb 8, 2024
Hans Edgar Bishop Director $22.5M Oct 7, 2024
Richard Mulligan Director $10.5M -$1.2M -10.2% Sep 24, 2024
Christian Hordo EVP, Chief Business Officer $3.68M Mar 7, 2024
James J. MacDonald EVP & General Counsel $3.02M Jun 13, 2022
Patrick Y. Yang Director $1.41M -$236K -14.3% Jun 6, 2024
Steve Harr President & CEO, Director $1.1M Mar 7, 2024
Susan D. Wyrick Acting Chief Financial Officer and Principal Accounting Officer; Exhibit List: Ex. 24 - Power of Attorney $573K Oct 4, 2024
Douglas E. Williams EVP & President, R&D $369K Mar 7, 2024
Nathan Hardy EVP, Chief Financial Officer $369K Mar 7, 2024
Bernard J. Cassidy EVP & General Counsel $243K Mar 7, 2024
Mary Agnes Wilderotter Director $28.4K Jun 6, 2024
Fmr Llc Other*, 10%+ Owner $237 Apr 1, 2024
Alise Reicin Director Jun 6, 2024
Douglas G. Cole Director Jun 6, 2024
Joshua H. Bilenker Director Jun 6, 2024
Flagship Pioneering Fund VII General Partner LLC 10%+ Owner Feb 12, 2024
Michelle Seitz Director Jun 6, 2024
Sunil Agarwal EVP, Head of Development & CMO Mar 3, 2022

Recent Insider Transactions by Companies or Individuals for Sana Biotechnology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.